1. AB0475 Changes in heart rate variability reflect changes in clinical status and patient reported outcomes in systemic lupus erythematosus: a longitudinal analysis. (15th June 2017) Authors: Thanou, A; Stavrakis, S; Reynolds, JC; Kamp, S; Kamp, P; James, JA; Merrill, JT Journal: Annals of the rheumatic diseases Issue: Volume 76(2017)Supplement 2 Page Start: 1217 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Anti-C1q antibodies in systemic lupus erythematosus. (January 2015) Authors: Orbai, A-M; Truedsson, L; Sturfelt, G; Nived, O; Fang, H; Alarcón, G S; Gordon, C; Merrill, JT; Fortin, P R; Bruce, I N; Isenberg, D A; Wallace, D J; Ramsey-Goldman, R; Bae, S-C; Hanly, J G; Sanchez-Guerrero, J; Clarke, A E; Aranow, C B; Manzi, S; Urowitz, M B Journal: Lupus Issue: Volume 24:Number 1(2015) Page Start: 42 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. OP0232 Sustained safety and efficacy over 10 years with belimumab (BEL) plus standard systemic lupus erythematosus (SLE) therapy (SOC) in patients with SLE. (15th June 2017) Authors: Wallace, DJ; Ginzler, EM; Merrill, JT; Furie, RA; Stohl, W; Chatham, W; Weinstein, A; McKay, J; McCune, WJ; Petri, M; Fettiplace, J; Roth, D; Ji, B; Heath, A Journal: Annals of the rheumatic diseases Issue: Volume 76(2017)Supplement 2 Page Start: 150 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. OP0234 Clinical and biologic effects of icosl blockade by amg 557 in subjects with lupus arthritis. (15th June 2017) Authors: Cheng, LE; Amoura, Z; Cheah, B; Hiepe, F; Sullivan, BA; Zhou, L; Arnold, GE; Tsuji, WH; Merrill, JT; Chung, JB Journal: Annals of the rheumatic diseases Issue: Volume 76(2017)Supplement 2 Page Start: 151 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. PO.6.132 A phase 2b study of afimetoran (BMS-986256) in patients with active systemic lupus erythematosus (SLE): optimization of a lupus clinical trial design. (27th September 2022) Authors: Ranganathan, U; Merrill, JT; Crow, MK; Delev, N; Banerjee, S; Grasela, D; Harrison, M; Shen, Y; Culotta, E; Greenberg, S; Shah, V Journal: Lupus science & medicine Issue: Volume 9(2022)Supplement 2 Page Start: A100 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. S11.2 Efficacy and safety of deucravacitinib, a selective TYK2 inhibitor, in patients with active systemic lupus erythematosus: results from a phase 2, randomized, double-blind, placebo-controlled study. (27th September 2022) Authors: Van Vollenhoven, R; Pike, M; Merrill, JT; Morand, E; Werth, VP; Hobar, C; Delev, N; Shah, V; Sharkey, B; Wegman, T; Catlett, I; Banerjee, S; Singhal, S Journal: Lupus science & medicine Issue: Volume 9(2022)Supplement 2 Page Start: A16 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. S15.2 Severe non-adherence to hydroxychloroquine is associated with flares, early damage, and mortality in systemic lupus erythematosus: data from 660 patients from the slicc inception cohort. (27th September 2022) Authors: Nguyen, Y; Blanchet, B; Urowitz, MB; Hanly, JG; Gordon, C; Bae, S; Romero-Dia, J; Sanchez-Guerrero, J; Clarke, AE; Bernatsky, S; Wallace, DJ; Isenberg, DA; Rahman, A; Merrill, JT; Fortin, PR; Gladman, DD; Bruce, IN; Petri, M; Ginzler, EM; Dooley, MA Journal: Lupus science & medicine Issue: Volume 9(2022)Supplement 2 Page Start: A23 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. SAT0219 Efficacy and safety of atacicept in patients with high disease activity in a 24-week, randomized, placebo-controlled, phase iib study (ADDRESS II). (15th June 2017) Authors: Merrill, JT; Wallace, DJ; Kao, A; Mateo, C Vazquez; Fraser, PA; Chang, P; Isenberg, D Journal: Annals of the rheumatic diseases Issue: Volume 76(2017)Supplement 2 Page Start: 856 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. SAT0236 Safety and disease activity changes in an extension of a phase IIB study of atacicept in patients with SLE (address II). (15th June 2017) Authors: Wallace, DJ; Isenberg, D; Wax, S; Kao, A; Chang, P; Fraser, PA; Merrill, JT Journal: Annals of the rheumatic diseases Issue: Volume 76(2017)Supplement 2 Page Start: 863 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗